ECSP088482A - DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS - Google Patents

DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS

Info

Publication number
ECSP088482A
ECSP088482A EC2008008482A ECSP088482A ECSP088482A EC SP088482 A ECSP088482 A EC SP088482A EC 2008008482 A EC2008008482 A EC 2008008482A EC SP088482 A ECSP088482 A EC SP088482A EC SP088482 A ECSP088482 A EC SP088482A
Authority
EC
Ecuador
Prior art keywords
beta
compounds
pharmaceutical compositions
compositions containing
drugs
Prior art date
Application number
EC2008008482A
Other languages
Spanish (es)
Inventor
Alexander Hillisch
Olaf Peters
Ralf Wyrwa
Walter Elger
Peter Droescher
Gudrun Reddersen
Katja Prelle
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ECSP088482A publication Critical patent/ECSP088482A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención provee prodrogas de estratrienos 8 beta-sustituidos de fórmula general (I), en los que el grupo Z está unido al esteroide, proceso para su producción, composiciones farmacéuticas que contienen estos compuestos así como también el uso de los mismos.Los compuestos de fórmula general I de acuerdo a la invención no se unen al receptor de estrógenos y/o beta. Los mismos se unen a anhidrasas carbónicas e inhiben a estas enzimas.This invention provides prodrugs of 8 beta-substituted estratrianes of general formula (I), in which the Z group is bound to the steroid, process for its production, pharmaceutical compositions containing these compounds as well as the use thereof. of general formula I according to the invention do not bind to the estrogen receptor and / or beta. They bind carbonic anhydrases and inhibit these enzymes.

EC2008008482A 2005-11-29 2008-05-29 DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS ECSP088482A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005057225A DE102005057225A1 (en) 2005-11-29 2005-11-29 New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders

Publications (1)

Publication Number Publication Date
ECSP088482A true ECSP088482A (en) 2008-06-30

Family

ID=37909446

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008482A ECSP088482A (en) 2005-11-29 2008-05-29 DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS

Country Status (14)

Country Link
EP (1) EP1957514A1 (en)
JP (1) JP2009517426A (en)
KR (1) KR20080072087A (en)
CN (1) CN101316856A (en)
AU (1) AU2006319382A1 (en)
BR (1) BRPI0619237A2 (en)
CA (1) CA2630438A1 (en)
CR (1) CR9997A (en)
DE (1) DE102005057225A1 (en)
EA (1) EA200801272A1 (en)
EC (1) ECSP088482A (en)
NO (1) NO20082918L (en)
WO (1) WO2007062876A1 (en)
ZA (1) ZA200805658B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974776B2 (en) 2013-12-05 2018-05-22 Karo Pharma Ab Estrogen receptor beta agonists for use in treating mesothelioma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152248A0 (en) * 2000-04-12 2003-05-29 Schering Ag 8beta-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
US7534780B2 (en) * 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102004025966A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs

Also Published As

Publication number Publication date
WO2007062876A1 (en) 2007-06-07
NO20082918L (en) 2008-06-27
JP2009517426A (en) 2009-04-30
CA2630438A1 (en) 2007-06-07
ZA200805658B (en) 2010-01-27
BRPI0619237A2 (en) 2011-09-20
CR9997A (en) 2008-09-22
EA200801272A1 (en) 2008-10-30
KR20080072087A (en) 2008-08-05
CN101316856A (en) 2008-12-03
DE102005057225A1 (en) 2007-05-31
EP1957514A1 (en) 2008-08-20
AU2006319382A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
ECSP066391A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
BRPI0607455A2 (en) compound, process for preparing same, use of a compound, and pharmaceutical composition
UY29530A1 (en) CHEMICAL COMPOUNDS
ECSP067025A (en) DERIVATIVES OF TETRAAZABENZO [e] AZULENO AND ITS ANALOGS
UY31524A1 (en) NEW COMPOUNDS 010
CL2007003423A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF Rheumatoid ARTHRITIS, ATEROSCLEROSIS, AMONG OTHER DISEASES
BRPI0712631B8 (en) compounds, processes for preparing a compound, pharmaceutical composition, use of a compound and combinations
BRPI0508622B8 (en) biphenyl compounds useful as muscarinic receptor antagonists, pharmaceutical composition, process, medicine and use of the compound.
UY32648A (en) NEW DERIVATIVES OF PYRIMIDINE AND ITS USE IN THE TREATMENT OF DISEASES
UY30976A1 (en) NEW DERIVATIVES OF QUINOLINA, PHARMACCUTIC COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS.
BRPI0717970B8 (en) 11betahsd1 inhibitor compound, pharmaceutical composition, and, use of the compound
DOP2011000172A (en) ORGANIC COMPOUNDS
ECSP099394A (en) DERIVATIVES OF QUINUCLIDINOL AS ANTOGONISTS OF MUSCARINIC RECEPTORS
BRPI0510453A (en) Substituted Morpholine Compounds for the Treatment of Central Nervous System Disorders
EA201000436A1 (en) STEROID [3,2-С] PYRAZOLIC COMPOUNDS WITH GLUCOCORTICOID ACTIVITY
ECSP078062A (en) 1,4-DIHYDROPIRIDINE-CONDENSED HETEROCICLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM
ECSP099425A (en) DERIVATIVES OF AMINA AND ITS USE IN DISEASES MEDIATED BY THE BETA 2 ADRENORECETOR
UY29607A1 (en) CHEMICAL COMPOUNDS
CL2007003223A1 (en) Compounds derived from n-substituted piperidinyl 4-arylsulfonamides, which act as modulators of the sfrp-1 protein; process to prepare the compounds; pharmaceutical composition comprising said co-compounds and use of the compounds to prepare medicaments for the treatment of diseases.
CR9407A (en) TETRAHYDROPIRIDOAZEPIN-8-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
BRPI0507435A (en) piperidinylcarbonylpyrrolidines compounds, processes for their preparation, pharmaceutical composition and use as melanocortin agonists
UY29003A1 (en) NEW HIDANTOINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THERAPY
GT200600017A (en) 4-SUBSTITUTED PHENYLTHETHYROCHINOLINES, PROCESS FOR PREPARATION, USE AS A MEDICINAL PRODUCT AND MEDICINAL PRODUCT
ATE485261T1 (en) SALICYLIC ACID DERIVATIVES
ECSP088482A (en) DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS